What Is GHK-Cu? Definition and What Research Reports
GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, a three–amino-acid peptide that occurs naturally in human plasma and binds copper ions with high affinity. Published research has described it in cell, animal and skin-permeation models in relation to tissue remodelling, antioxidant signalling and gene expression. It is widely used as a cosmetic ingredient and as a research compound. This glossary entry defines the term, explains the biochemistry, and summarises what the cited literature reported.
Plain definition
GHK-Cu is a very small peptide — just three amino acids — joined to a copper ion. The three amino acids are glycine, histidine and lysine, which is why the peptide is written as GHK (using the single-letter codes) or spelled out as glycyl-L-histidyl-L-lysine. The "-Cu" on the end is the chemical symbol for copper. GHK occurs naturally in human blood plasma, and because the histidine and lysine residues form a strong binding pocket for copper(II), the peptide is usually discussed in its copper-bound form. Reviews of the literature have framed GHK-Cu primarily as a copper-carrying signalling molecule studied in connection with tissue repair, skin, and gene expression rather than as a structural building block (PMID 29986520).
This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question. Nothing here describes how any substance should be used.
What GHK-Cu is in biochemical terms
Chemically, GHK is a tripeptide with the sequence Gly-His-Lys and a molecular weight of roughly 340 daltons in its free form. The imidazole nitrogen of histidine, the N-terminal amine and the adjacent peptide nitrogen together chelate a divalent copper ion, producing the square-planar complex written as GHK-Cu(II) or GHK-Cu2+. This copper-binding behaviour is the defining feature of the molecule and the reason researchers describe it as a copper transport or copper-delivery peptide.
Literature reviews have grouped the described activities of GHK-Cu into a few recurring themes: interaction with extracellular matrix components, modulation of antioxidant and inflammatory signalling, and effects on gene expression profiles observed in cultured cells (PMID 29986520). A 2008 review on GHK and tissue remodelling summarised early work describing the peptide's association with matrix turnover and repair processes (PMID 18644225). An overview framing GHK as a candidate anti-aging peptide covered the same themes and discussed reported declines in plasma GHK with advancing age (PMID 35083444).
Naming and synonyms
| Term | What it refers to |
|---|---|
| GHK | The free tripeptide glycyl-L-histidyl-L-lysine, without bound copper |
| GHK-Cu / GHK-Cu(II) | The copper(II)-bound complex of the same tripeptide |
| Copper peptide | Informal umbrella term; often means GHK-Cu but can mean other copper-binding peptides |
| Copper tripeptide-1 | Cosmetic ingredient nomenclature commonly used on product labels |
| Cu-GHK | Alternative ordering of the same name used in some papers |
How the term is used in peptide research
In published research, "GHK-Cu" usually appears in one of four contexts.
- Skin and matrix biology. An in vitro study reported that the tripeptide-copper complex stimulated matrix metalloproteinase-2 expression in fibroblast cultures (PMID 11045606). Matrix metalloproteinases are enzymes involved in remodelling the extracellular matrix, and this paper is frequently cited as mechanistic background for the peptide's association with tissue remodelling (PMID 18644225).
- Topical and cosmetic formulation science. A 2025 review examined topically applied GHK as an anti-wrinkle peptide and discussed both the claimed advantages and the formulation problems that remain unresolved, including stability and delivery (PMID 39963574). A separate 2025 methodological paper asked whether current techniques are adequate to measure skin permeation of GHK-Cu encapsulated in liposomes, highlighting that permeation measurement itself is a contested technical question (PMID 39795193).
- Oxidative stress and organ injury models. Animal and cell studies have examined GHK-Cu in lung and muscle injury models. Researchers reported that GHK-Cu attenuated cigarette smoke–induced pulmonary emphysema and inflammation through reduction of oxidative stress pathways (PMID 35936787), that it attenuated lung inflammation and fibrosis in a silicosis model by targeting peroxiredoxin 6 (PMID 38879894), and that it rescued cigarette smoking–induced skeletal muscle dysfunction via a sirtuin 1–dependent pathway (PMID 36905132). These were experimental models, not clinical trials in people.
- Biomaterials and non-medical chemistry. GHK has been conjugated to other molecules for materials research: a 2025 study described copper complexes of GHK–hyaluronan conjugates with antioxidant properties and synergistic osteogenic and angiogenic effects in laboratory assays (PMID 40123442). Outside biomedicine entirely, Cu-GHK was reported as a high-efficiency inducer for laccase production by the fungus Trametes versicolor (PMID 37180036), which illustrates that the term appears in industrial biotechnology as well.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeWhere the term is misused
Several patterns of loose usage appear in non-scientific writing about GHK-Cu.
Treating GHK and GHK-Cu as interchangeable
The free peptide and the copper complex are not the same chemical entity. Much of the literature describes the copper-bound form specifically, and reviews have emphasised that copper binding is central to the described biology (PMID 29986520). Writing that attributes findings about GHK-Cu to bare GHK, or vice versa, blurs a real distinction.
Generalising from cell and animal models to people
The lung, muscle and fibroblast findings above were generated in cultured cells and animal models (PMID 38879894, PMID 36905132). Descriptions that present those model results as established human outcomes go beyond what the cited papers reported.
Assuming topical application equals systemic delivery
A hydrophilic, copper-chelating tripeptide does not automatically cross the stratum corneum. The 2025 liposome permeation paper framed measurement of GHK-Cu skin penetration as an open methodological problem rather than a settled fact (PMID 39795193), and the topical anti-wrinkle review discussed unresolved delivery problems alongside the claimed advantages (PMID 39963574).
"Copper peptide" as a catch-all
Cosmetic marketing often uses "copper peptide" without specifying the sequence or the copper-to-peptide ratio. Since the literature is sequence-specific, the generic label is not a reliable indicator of what was studied.
Safety and tolerability: What Studies Report
The verified papers summarised here were predominantly mechanistic reviews, cell studies, animal models and formulation research; they were not designed as human safety trials, and none of them established a safety profile for human use. The 2025 topical review explicitly discussed "problems" alongside advantages for topically applied GHK, indicating that formulation and delivery limitations were treated as unresolved in that literature (PMID 39963574). Reviews of GHK-Cu's regenerative and protective actions summarised gene-expression and mechanistic data rather than adverse-event tabulations (PMID 29986520, PMID 35083444). Readers should not infer tolerability from the absence of reported adverse events in studies that did not set out to collect them.
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appRegulatory status in plain terms
GHK-Cu (often labelled copper tripeptide-1) appears as an ingredient in cosmetic products in many markets, where cosmetic ingredient rules rather than drug approval rules apply. Separately, GHK-Cu is sold in some jurisdictions as a research-use-only chemical, a designation that means it is intended for laboratory work and is not an approved medicine. There is no approved GHK-Cu prescription drug product for systemic use in the United States. Regulatory categories differ by country and change over time; this section is descriptive background, not legal advice.
Related terms
- Tripeptide — a peptide of three amino acid residues; GHK is the canonical example discussed in copper biology.
- Chelation — the binding of a metal ion by multiple donor atoms on one molecule; the basis of GHK's copper affinity.
- Extracellular matrix (ECM) — the protein and polysaccharide scaffold between cells; the setting for the remodelling literature (PMID 18644225).
- Matrix metalloproteinase (MMP) — ECM-degrading enzymes; MMP-2 expression in fibroblasts was a reported readout in one cell study (PMID 11045606).
- Peroxiredoxin 6 and sirtuin 1 — the molecular targets identified in the silicosis and skeletal-muscle model papers respectively (PMID 38879894, PMID 36905132).
- Liposomal encapsulation — a delivery strategy examined in the skin-permeation methodology paper (PMID 39795193).
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeWhat the literature does and does not settle
Across the cited papers, researchers consistently described GHK-Cu as a copper-binding tripeptide with measurable effects on gene expression, antioxidant signalling and matrix-related enzymes in laboratory systems (PMID 29986520, PMID 11045606). What the verified literature did not provide was large controlled human outcome data, a defined systemic exposure profile, or resolved answers about topical penetration (PMID 39795193, PMID 39963574). A precise glossary definition therefore stops at chemistry and research context rather than extending to claims about outcomes in people.
References
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (International Journal of Molecular Sciences, 2018)
- The potential of GHK as an anti-aging peptide (Aging Pathobiology and Therapeutics, 2020)
- Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective (BioImpacts, 2025)
- Glycyl-l-histidyl-l-lysine-Cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway (Journal of Cachexia, Sarcopenia and Muscle, 2023)
- The glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6 (Redox Biology, 2024)
- Glycyl-L-histidyl-L-lysine-Cu(2+) attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway (Frontiers in Molecular Biosciences, 2022)
- The human tri-peptide GHK and tissue remodeling (Journal of Biomaterials Science, Polymer Edition, 2008)
- Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects (Bioconjugate Chemistry, 2025)
- Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer (Frontiers in Bioengineering and Biotechnology, 2023)
- The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures (Life Sciences, 2000)
- Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? (Molecules, 2025)
Frequently asked questions
What does GHK-Cu stand for?▾
GHK stands for the three amino acids in the peptide — glycine, histidine and lysine — using their single-letter codes, and "Cu" is the chemical symbol for copper. The full chemical name is glycyl-L-histidyl-L-lysine copper(II). Reviews describe it as a naturally occurring human plasma tripeptide whose copper-binding property underlies most of the biology studied (PMID 29986520, PMID 35083444).
Is GHK the same thing as GHK-Cu?▾
No. GHK refers to the free tripeptide; GHK-Cu refers to the same peptide bound to a copper(II) ion. Much of the published research specifically examined the copper complex, and reviews have treated copper binding as central to the described activity (PMID 29986520). Conflating the two terms misrepresents which chemical entity a given study actually tested.
What has research reported about GHK-Cu in laboratory models?▾
In cultured fibroblasts, one study reported that the tripeptide-copper complex stimulated matrix metalloproteinase-2 expression (PMID 11045606). In animal models, researchers reported that GHK-Cu attenuated cigarette smoke–induced pulmonary emphysema and inflammation via oxidative stress pathways (PMID 35936787) and attenuated lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6 (PMID 38879894). These were preclinical models, not human trials.
Why is GHK-Cu called a copper peptide?▾
Because the histidine imidazole nitrogen, the N-terminal amine and an adjacent peptide nitrogen together chelate a copper(II) ion, making the peptide an efficient copper carrier. "Copper peptide" is an informal umbrella term used in cosmetic writing and can refer to other copper-binding sequences too, so it is less precise than naming GHK-Cu or copper tripeptide-1 directly (PMID 29986520).
Does GHK-Cu penetrate the skin when applied topically?▾
That question was not settled in the cited literature. A 2025 methodological paper asked whether current techniques are even adequate to measure skin permeation of liposome-encapsulated GHK-Cu (PMID 39795193), and a 2025 review of topically applied GHK discussed unresolved formulation and delivery problems alongside claimed advantages (PMID 39963574).
What adverse events have studies reported for GHK-Cu?▾
The verified papers were mainly mechanistic reviews, cell studies, animal models and formulation research, and were not designed to collect human adverse-event data, so no safety profile was established (PMID 29986520, PMID 35083444). One 2025 review discussed formulation and delivery problems for topical GHK as unresolved issues (PMID 39963574). Absence of reported events in such studies is not evidence of safety.
Is GHK-Cu used outside of medicine and skincare?▾
Yes. Researchers conjugated GHK to hyaluronan and reported copper complexes with antioxidant properties and synergistic osteogenic and angiogenic effects in laboratory assays (PMID 40123442). In industrial biotechnology, Cu-GHK was reported as a high-efficiency inducer for laccase production by the fungus Trametes versicolor (PMID 37180036).
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.